Axxam SpA enters into a collaboration agreement with Bayer HealthCare for the provision of Drug Discovery Services

July 21st, 2015 – Axxam SpA (Milan/Italy), a leading provider of discovery services has entered into a multi-year collaboration agreement with Bayer HealthCare (Bayer), a global pharmaceutical company. The aim of this collaboration is to provide high level services to support Bayer’s strong commitment to discover new therapies for diseases with high unmet medical need.